Optimal length of time of cryopreserved umbilical cord blood infusion after thawing

References

• Gluckman E. Milestones in umbilical cord blood transplantation. Blood Rev. 2011;25(6):255–9.
   PubMed Web of Science ®Google Scholar
• Dalle JH, Duval M, Moghrabi A, Wagner E, Vachon MF, Barrette S, et al. Results of unrelated transplant search strategy using partially HLA-mismatched cord blood as an immediate alternative to HLA-matched bone marrow. Bone Marrow Transplant. 2004;33:605–11.
   PubMed Web of Science ®Google Scholar
• Douay L, Gorin NC, David R, Stachowiak J, Salmon C, Najman A, et al. Study of granulocyte-macrophage progenitor (CFUc) preservation after slow freezing of bone marrow in the gas phase of liquid nitrogen. Exp Hematol. 1982;10:360–6.
   PubMed Web of Science ®Google Scholar
• Konuma T, Ooi J, Takahashi S, Tomonari A, Tsukada N, Kobayashi T, et al. Cardiovascular toxicity of cryopreserved cord blood cell infusion. Bone Marrow Transplant. 2008;41:861–5.
   PubMed Web of Science ®Google Scholar
• Petterson TE, Gabriel M, Tiedemann K, Teague L, Shaw PJ, Baker D, et al. Outcome following unrelated cord blood transplant in 136 patients with malignant and non-malignant diseases: a report from the Australian and New Zealand children's haematology and oncology group. Bone Marrow Transplant. 2009;43:207–15.
   PubMed Web of Science ®Google Scholar
• Hahn T, Bunworasate U, George MC, Bir AS, Chinratanalab W, Alam AR, et al. Use of nonvolume-reduced (unmanipulated after thawing) umbilical cord blood stem cells for allogeneic transplantation results in safe engraftment. Bone Marrow Transplant. 2003;32:145–50.
   PubMed Web of Science ®Google Scholar
• Ruiz-Delgado GJ, Mancías-Guerra C, Tamez-Gómez EL, Rodríguez-Romo LN, López-Otero A, Hernández-Arizpe A, et al. Dimethyl sulfoxide-induced toxicity in cord blood stem cell transplantation: report of three cases and review of the literature. Acta Haematol. 2009;122:1–5.
   PubMed Web of Science ®Google Scholar
• Ma RW, Kwan JM, Ma DD, Fay KC. Acute life-threatening cardiovascular toxicity with umbilical cord blood infusion: the role of dextran. Am J Hematol. 2010;85:722–4.
   PubMed Web of Science ®Google Scholar
• Petropoulou AD, Bellochine R, Norol F, Marie JP, Rio B. Coronary artery spasm after infusion of cryopreserved cord blood cells. Bone Marrow Transplant. 2007;40:397–8.
   PubMed Web of Science ®Google Scholar
• KLIGMAN AM. Topical pharmacology and toxicology of dimethylsulfoxide.1. JAMA. 1965;193:796–804.
   PubMed Web of Science ®Google Scholar
• Chaloupka JC, Huddle DC, Alderman J, Fink S, Hammond R, Vinters HV. A reexamination of the angiotoxicity of superselective injection of DMSO in the swine rete embolization model. AJNR Am J Neuroradiol. 1999;20:401–10.
   PubMed Web of Science ®Google Scholar
• Shlafer M, Karow AM Jr. Pharmacological effects of dimethyl sulfoxide on the mammalian myocardium. Ann N Y Acad Sci. 1975;243:110–21.
   PubMed Web of Science ®Google Scholar
• Milone G, Mercurio S, Strano A, Leotta S, Pinto V, Battiato K, et al. Adverse events after infusions of cryopreserved hematopoietic stem cells depend on non-mononuclear cells in the infused suspension and patient age. Cytotherapy. 2007;9:348–55.
   PubMed Web of Science ®Google Scholar
• Beaujean F, Hartmann O, Kuentz M, Le Forestier C, Divine M, Duedari N. A simple, efficient washing procedure for cryopreserved human hematopoietic stem cells prior to reinfusion. Bone Marrow Transplant. 1991;8:291–4.
   PubMed Web of Science ®Google Scholar
• Regan DM, Wofford JD, Wall DA. Comparison of cord blood thawing methods on cell recovery, potency, and infusion. Transfusion 2010;50:2670–5.
   PubMed Web of Science ®Google Scholar
• Wu JY, Liao C, Xu ZP, Chen JS, Gu SL, Huang YN, et al. Banking and transplantation of umbilical cord blood in Guangzhou, China. Cytotherapy. 2006;8:488–97.
   PubMed Web of Science ®Google Scholar
• Liu J, Zhou SY, Huang GD, Huang Y, Wang YS, Chen DZ, et al. Cryobiological characteristics of placental cord blood preserved in BioArchive auto-preserved liquid nitrogen system. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2002;10:261–4.
   PubMedGoogle Scholar
• Hayakawa J, Joyal EG, Gildner JF, Washington KN, Phang OA, Uchida N, et al. 5% Dimethyl sulfoxide (DMSO) and pentastarch improves cryopreservation of cord blood cells over 10% DMSO. Transfusion 2010;50:2158–66.
   PubMed Web of Science ®Google Scholar
• Picardi A, Arcese W. Quality assessment of cord blood units selected for unrelated transplantation: a transplant center perspective. Transfus Apheresis Sci. 2010;42:289–97.
   PubMed Web of Science ®Google Scholar
• Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol. 1992;148:2207–16.
   PubMed Web of Science ®Google Scholar
• Wagner JE, Barker JN, DeFor TE, Baker KS, Blazar BR, Eide C, et al. Transplantation of unrelated donor cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood. 2002;100:1611–8.
   PubMed Web of Science ®Google Scholar
• Allan DS, Keeney M, Howson-Jan K, Popma J, Weir K, Bhatia M, et al. Number of viable CD34+ cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation. Bone Marrow Transplant. 2002;29:967–72.
   PubMed Web of Science ®Google Scholar
• Weaver CH, Hazelton B, Birch R, Palmer P, Allen C, Schwartzberg L, et al. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collection in 692 patients after the administration of myeloablative chemotherapy. Blood. 1995;86:3961–9.
   PubMed Web of Science ®Google Scholar
• Duggleby RC, Querol S, Davy RC, Fry LJ, Gibson DA, Horton RB, et al. Flow cytometry assessment of apoptotic CD34+cells by annexin V labeling may improve prediction of cord blood potency for engraftment. Transfusion 2012;52:549–59.
   PubMed Web of Science ®Google Scholar
• de Boer F, Dräger AM, Pinedo HM, Kessler FL, Monnee-van Muijen M, Weijers G, et al. Early apoptosis largely accounts for functional impairment of CD34+ cells in frozen-thawed stem cell grafts. J Hematother Stem Cell Res. 2002;11:951–63.
   PubMedGoogle Scholar
• Sparrow RL, Komodromou H, Tippett E, Georgakopoulos T, Xu W. Apoptotic lymphocytes and CD34+ cells in cryopreserved cord blood detected by the fluorescent vital dye SYTO 16 and correlation with loss of L-selectin (CD62L) expression. Bone Marrow Transplant. 2006;38:61–7.
   PubMed Web of Science ®Google Scholar
• Iori AP, Cerretti R, De Felice L, Screnci M, Mengarelli A, Romano A, et al. Pre-transplant prognostic factors for patients with high-risk leukemia undergoing an unrelated cord blood transplantation. Bone Marrow Transplant. 2004;33:1097–105.
   PubMed Web of Science ®Google Scholar
• Prasad VK, Mendizabal A, Parikh SH, Szabolcs P, Driscoll TA, Page K, et al. Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes. Blood. 2008;112:2979–89.
   PubMed Web of Science ®Google Scholar
• Alonso JM III, Regan DM, Johnson CE, Oliver DA, Fegan R, Lasky LC, et al. A simple and reliable procedure for cord blood banking, processing, and freezing: St Louis and Ohio Cord Blood Bank experiences. Cytotherapy. 2001;3:429–33.
   PubMed Web of Science ®Google Scholar
• Goldman JM, Th'ng KH, Park DS, Spiers AS, Lowenthal RM, Ruutu T. Collection, cryopreservation and subsequent viability of haemopoietic stem cells intended for treatment of chronic granulocytic leukaemia in blast-cell transformation. Br J Haematol 1978;40:185–95.
   PubMed Web of Science ®Google Scholar